Lonza appoints Christian Seufert as President of CHI Division
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
Successful proposals will secure fully funded postdoctoral research positions
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
Subscribe To Our Newsletter & Stay Updated